Finally, we demonstrated that the RAD51 assay is feasible in formalin‐fixed paraffin‐embedded (FFPE) routine breast cancer samples and accurately classified as HRR‐deficient all the PALB2‐related tumors. The gene discussed is RAD51; the disease is breast cancer.